About Us

Our Story: The Vision of a Veteran

PoD was conceptualized by the co-founder, Geoff Ling, M.D., Ph.D. while he was serving as a Lt. Col. in the U.S. Army. While Dr. Ling was deployed at a combat hospital in Afghanistan, a wounded American soldier needed a life-saving treatment that wasn’t available onsite. They had to have it flown in from Ramstein Air Base in Germany. Dr. Ling’s frustration turned to inspiration when he realized he could have made the drug himself with some simple starting ingredients. That idea was realized through work at MIT funded by DARPA. Dr. Ling co-founded On Demand Pharmaceuticals to move PoD to commercialization and bring this much-needed technology to the world.

This is a true ‘Made in America’ end-to-end solution that eliminates our Nation’s dependency on other countries for critical life-saving medicines.


ODP Leadership

Executive Team


COL USA (r)
Geoff Ling, MD, PhD Founder and CEO
Neuro-intensive care physician and Professor at Johns Hopkins Hospital, former founding Director of the Biological Technologies Office at DARPA. Click to expand


Tyler McQuade, PhD
Chief Innovation Officer
Organic chemist, former Program Manager and Deputy Director of the Defense Sciences Office at DARPA and professor at Cornell and VCU. Click to expand


Naomi Briggs, PhD
VP of Drug Substance Purification
PhD from the University of Strathclyde, Glasgow, UK, Postdoctoral Associate at Massachusetts Institute of Technology, former Lead Engineer at Alkermes. Click to expand

John Lewin, PharmD, MBA
CMO and Plank Holder
Chief Pharmacist for the Johns Hopkins Critical Care & Surgery Pharmacy and Associate Professor at Johns Hopkins. Click to expand

Andrew Bryon
COO and Plank Holder
Former DARPA Biological Technologies Office, Senior Business and Finance Manager. Click to expand

Kari Stoever
Chief External Relations Officer
Global Health and Development Expert. Former RN, BS Clinical Research George Washington University, Master’s in Leadership McDonough School of Business, Georgetown University. Click to expand

Eugene Choi, PhD
CTO and Plank Holder
Process chemical and biomedical engineer, former subject matter expert at DARPA and Executive Director of the Medicines for All Institute. Click to expand

Luke Rogers, PhD
VP of Chemical Synthesis
PhD from Trinity College Dublin, Ireland, Postdoctoral Associate at Massachusetts Institute of Technology, former Process Chemist at Merck & co. Click to expand

Board of Directors

undefined
David A. Steinberg
Co-Founder and Chairman, CEO of Zeta

COL USA (r) Geoff Ling, MD, PhD
Founder and CEO

John Sculley
Co-Founder of Zeta Global, former CEO of Pepsi and Apple


William Landman
Co-Founder of MainLine Investment

Robert Niehaus
Founder of GCP Capital

 

 

 


Scientific Advisors

Allan Myerson, PhD
Professor, Massachusetts Institute of Technology Chemical Engineering

Klavs Jensen, PhD
Professor, Massachusetts Institute of Technology Chemical Engineering

Tim Jamison, PhD
Professor, Massachusetts Institute of Technology Chemistry

Andrea Adamo, PhD
Founder and CEO of Zaiput Flow Technologies

Peter Haaland, PhD
Founding General Partner of InnerProduct Partners

Jon Mogford, PhD
Vice Chancellor for Research for Texas A&M University

Michael Callahan, MD, DTM&H, MSPH
President, United Therapeutics Division of Cellular Therapeutics; Associate Physician, Division of Infectious Diseases, Mass General Hospital

Govind Rao, PhD
Professor, UMBC Chemical & Biochemical Engineering


COMPANY ADVISORS

Jay Bapna
Former Senior VP of Global Manufacturing, Allergan

Leo Christodoulou
Former Director of Structures and Materials, Enterprise Operations and Technology, Boeing

Mick Maher, Former Chief of Composites and Materials, Army Research Labs, former Manufacturing Engineer, Martin Marietta and former Master Planner, Middle River Aviation

Craig Odell “Chip” Bailey, Jr., Currently Managing Member, Mandeville Advisors, LLC; Former Executive Vice President, NWQ Investment Management Company, LLC; Former Founder and Managing Member, Westbourne Capital Management, LLC; Former Managing Director, TCW Group, Inc.


Investors

Michael Milken
Founder of the Milken Institute

Fred Wilson
Co-Founder of Union Square Ventures

Richard Merkin, MD
CEO of Heritage Group

Karen Ling
Executive VP at AIG